Embed presentation
Download to read offline






A non-invasive maternal blood test called cell-free fetal DNA (cffDNA) detects certain fetal chromosomal disorders, including Down syndrome, with an accuracy of about 85% and a false positive rate of 5%. It is used for high-risk pregnant women, although invasive tests like CVS and amniocentesis are needed for confirmation. The test screens for three conditions and can identify up to 98% of Down syndrome cases with a much lower false positive rate than traditional methods.




